Cargando…

Spinal fusion with motor evoked potential monitoring using remimazolam in Alström syndrome: A case report

RATIONALE: Alström syndrome is a rare genetic disorder characterized by obesity, diabetes mellitus, cardiomyopathy, and liver dysfunction. Further, scoliosis, a common symptom of Alström syndrome, often requires surgical intervention for functional impairments. Motor evoked potential (MEP) monitorin...

Descripción completa

Detalles Bibliográficos
Autores principales: Arashiro, Ayako, Shinzato, Hayato, Kamizato, Kota, Kakinohana, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615471/
https://www.ncbi.nlm.nih.gov/pubmed/34964794
http://dx.doi.org/10.1097/MD.0000000000027990
_version_ 1784604112799662080
author Arashiro, Ayako
Shinzato, Hayato
Kamizato, Kota
Kakinohana, Manabu
author_facet Arashiro, Ayako
Shinzato, Hayato
Kamizato, Kota
Kakinohana, Manabu
author_sort Arashiro, Ayako
collection PubMed
description RATIONALE: Alström syndrome is a rare genetic disorder characterized by obesity, diabetes mellitus, cardiomyopathy, and liver dysfunction. Further, scoliosis, a common symptom of Alström syndrome, often requires surgical intervention for functional impairments. Motor evoked potential (MEP) monitoring and other electrophysiological tests are essential when performing surgery for functional scoliosis. However, there are few reports on how to maintain general anesthesia in Alström syndrome. Here, we describe a patient with Alström syndrome who underwent surgery for scoliosis under general anesthesia with remimazolam and MEP monitoring. PATIENT CONCERNS: A 17-year-old woman (height, 140 cm, weight, 64.5 kg) diagnosed with Alström syndrome was scheduled for a posterior spinal fusion for functional scoliosis. Other associated comorbidities of Alström syndrome present were dilated cardiomyopathy, type 2 diabetes mellitus, obesity (body mass index, 32.1 kg/m(2)), amblyopia (light perception), and hearing impairment (speech awareness threshold 50 dBHL in each ear). DIAGNOSES, INTERVENTIONS, AND OUTCOMES: Posterior spinal fusion was planned for functional scoliosis. While investigating the dilated cardiomyopathy, transthoracic echocardiography showed global wall hypokinesis, with 45% left ventricular ejection fraction. The left ventricle was dilated, with left ventricular end-diastolic and end-systolic diameters of 55 and 42 mm, respectively. This finding along with the hypertriglyceridemia associated with Alström syndrome led us to conclude that propofol should be avoided. Thus, we induced general anesthesia using remimazolam. MEP monitoring was performed, and the patient experienced no motor impairments during the surgery. LESSONS: Myocardial and hepatic dysfunction determine the prognosis of patients with Alström syndrome. Thus, anesthesia that preserves liver function should be selected in such cases. In patients with hypertriglyceridemia, propofol should be avoided, and using remimazolam, an ultrashort-acting benzodiazepine, may be appropriate. In this case, reviewing the Patient State Index with SedLine allowed us to perform MEP monitoring uneventfully, and the posterior spinal fusion was completed without any motor impairment.
format Online
Article
Text
id pubmed-8615471
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-86154712021-11-29 Spinal fusion with motor evoked potential monitoring using remimazolam in Alström syndrome: A case report Arashiro, Ayako Shinzato, Hayato Kamizato, Kota Kakinohana, Manabu Medicine (Baltimore) 3300 RATIONALE: Alström syndrome is a rare genetic disorder characterized by obesity, diabetes mellitus, cardiomyopathy, and liver dysfunction. Further, scoliosis, a common symptom of Alström syndrome, often requires surgical intervention for functional impairments. Motor evoked potential (MEP) monitoring and other electrophysiological tests are essential when performing surgery for functional scoliosis. However, there are few reports on how to maintain general anesthesia in Alström syndrome. Here, we describe a patient with Alström syndrome who underwent surgery for scoliosis under general anesthesia with remimazolam and MEP monitoring. PATIENT CONCERNS: A 17-year-old woman (height, 140 cm, weight, 64.5 kg) diagnosed with Alström syndrome was scheduled for a posterior spinal fusion for functional scoliosis. Other associated comorbidities of Alström syndrome present were dilated cardiomyopathy, type 2 diabetes mellitus, obesity (body mass index, 32.1 kg/m(2)), amblyopia (light perception), and hearing impairment (speech awareness threshold 50 dBHL in each ear). DIAGNOSES, INTERVENTIONS, AND OUTCOMES: Posterior spinal fusion was planned for functional scoliosis. While investigating the dilated cardiomyopathy, transthoracic echocardiography showed global wall hypokinesis, with 45% left ventricular ejection fraction. The left ventricle was dilated, with left ventricular end-diastolic and end-systolic diameters of 55 and 42 mm, respectively. This finding along with the hypertriglyceridemia associated with Alström syndrome led us to conclude that propofol should be avoided. Thus, we induced general anesthesia using remimazolam. MEP monitoring was performed, and the patient experienced no motor impairments during the surgery. LESSONS: Myocardial and hepatic dysfunction determine the prognosis of patients with Alström syndrome. Thus, anesthesia that preserves liver function should be selected in such cases. In patients with hypertriglyceridemia, propofol should be avoided, and using remimazolam, an ultrashort-acting benzodiazepine, may be appropriate. In this case, reviewing the Patient State Index with SedLine allowed us to perform MEP monitoring uneventfully, and the posterior spinal fusion was completed without any motor impairment. Lippincott Williams & Wilkins 2021-11-24 /pmc/articles/PMC8615471/ /pubmed/34964794 http://dx.doi.org/10.1097/MD.0000000000027990 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 3300
Arashiro, Ayako
Shinzato, Hayato
Kamizato, Kota
Kakinohana, Manabu
Spinal fusion with motor evoked potential monitoring using remimazolam in Alström syndrome: A case report
title Spinal fusion with motor evoked potential monitoring using remimazolam in Alström syndrome: A case report
title_full Spinal fusion with motor evoked potential monitoring using remimazolam in Alström syndrome: A case report
title_fullStr Spinal fusion with motor evoked potential monitoring using remimazolam in Alström syndrome: A case report
title_full_unstemmed Spinal fusion with motor evoked potential monitoring using remimazolam in Alström syndrome: A case report
title_short Spinal fusion with motor evoked potential monitoring using remimazolam in Alström syndrome: A case report
title_sort spinal fusion with motor evoked potential monitoring using remimazolam in alström syndrome: a case report
topic 3300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615471/
https://www.ncbi.nlm.nih.gov/pubmed/34964794
http://dx.doi.org/10.1097/MD.0000000000027990
work_keys_str_mv AT arashiroayako spinalfusionwithmotorevokedpotentialmonitoringusingremimazolaminalstromsyndromeacasereport
AT shinzatohayato spinalfusionwithmotorevokedpotentialmonitoringusingremimazolaminalstromsyndromeacasereport
AT kamizatokota spinalfusionwithmotorevokedpotentialmonitoringusingremimazolaminalstromsyndromeacasereport
AT kakinohanamanabu spinalfusionwithmotorevokedpotentialmonitoringusingremimazolaminalstromsyndromeacasereport